open access

Vol 62, No 1 (2011)
Review article
Published online: 2011-03-01
Submitted: 2013-02-15
Get Citation

Osteonecrosis of the jaw

Bogna Drozdzowska
Endokrynologia Polska 2011;62(1):88-92.

open access

Vol 62, No 1 (2011)
Review article
Published online: 2011-03-01
Submitted: 2013-02-15

Abstract

This review looks at osteonecrosis in the stomatognathic system (mainly the jaws). Osteonecrosis of the jaw (ONJ) is a rare but serious clinical condition. It affects patients treated with bisphosphonates, and also with denosumab, mainly in oncological doses. In osteoporosis, it is a problem of relatively small significance. Article presents a thorough review of this phenomenon, including its definition, pathogenesis, risk factors, prevention and treatment methods, and its incidence rate. (Pol J Endocrinol 2011; 62 (1): 88-92)

Abstract

This review looks at osteonecrosis in the stomatognathic system (mainly the jaws). Osteonecrosis of the jaw (ONJ) is a rare but serious clinical condition. It affects patients treated with bisphosphonates, and also with denosumab, mainly in oncological doses. In osteoporosis, it is a problem of relatively small significance. Article presents a thorough review of this phenomenon, including its definition, pathogenesis, risk factors, prevention and treatment methods, and its incidence rate. (Pol J Endocrinol 2011; 62 (1): 88-92)
Get Citation

Keywords

osteonecrosis of the jaw; bisphosphonates; denosumab

About this article
Title

Osteonecrosis of the jaw

Journal

Endokrynologia Polska

Issue

Vol 62, No 1 (2011)

Pages

88-92

Published online

2011-03-01

Bibliographic record

Endokrynologia Polska 2011;62(1):88-92.

Keywords

osteonecrosis of the jaw
bisphosphonates
denosumab

Authors

Bogna Drozdzowska

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl